Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

(3-Hydroxy-3H-1,2,3-Triazolo[4,5-B]Pyridinato-O)Tri-1-Pyrrolidinylphosphonium Hexafluorophosphate

    • Product Name (3-Hydroxy-3H-1,2,3-Triazolo[4,5-B]Pyridinato-O)Tri-1-Pyrrolidinylphosphonium Hexafluorophosphate
    • Alias PyBOP
    • Einecs 695-823-8
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    207414

    Product Name (3-Hydroxy-3H-1,2,3-Triazolo[4,5-B]Pyridinato-O)Tri-1-Pyrrolidinylphosphonium Hexafluorophosphate
    Synonyms PyAOP
    Cas Number 163867-37-6
    Molecular Formula C17H28F6N7O2P2
    Molecular Weight 553.39
    Appearance White to off-white solid
    Solubility Soluble in DMF, DMSO, and NMP
    Melting Point 169-173°C (decomposes)
    Application Peptide coupling reagent
    Storage Conditions Store at 2-8°C, protected from moisture
    Sensitivity Moisture sensitive
    Purity Typically ≥98%
    Hazard Class Irritant

    As an accredited (3-Hydroxy-3H-1,2,3-Triazolo[4,5-B]Pyridinato-O)Tri-1-Pyrrolidinylphosphonium Hexafluorophosphate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Amber glass bottle containing 5 grams of white to off-white solid, tightly sealed with a screw cap and tamper-evident label.
    Shipping This chemical is shipped in tightly sealed containers under dry, cool conditions to prevent moisture exposure and degradation. Packaging complies with local and international regulations. It is labeled as a hazardous material, typically shipped with appropriate documentation and safety data, ensuring limited access and proper handling during transit to minimize risks of leakage or contamination.
    Storage Store (3-Hydroxy-3H-1,2,3-triazolo[4,5-b]pyridinato-O)tri-1-pyrrolidinylphosphonium hexafluorophosphate in a tightly sealed container, under a dry, inert atmosphere, away from moisture and incompatible substances. Keep at room temperature or as specified by supplier, protected from light. Store in a cool, well-ventilated area, and follow standard laboratory safety procedures for handling and storage of reactive phosphorus and fluorinated compounds.
    Application of (3-Hydroxy-3H-1,2,3-Triazolo[4,5-B]Pyridinato-O)Tri-1-Pyrrolidinylphosphonium Hexafluorophosphate

    Applications of (3-Hydroxy-3H-1,2,3-Triazolo[4,5-B]Pyridinato-O)Tri-1-Pyrrolidinylphosphonium Hexafluorophosphate in Industrial Manufacturing

    Our production of (3-Hydroxy-3H-1,2,3-Triazolo[4,5-B]Pyridinato-O)Tri-1-Pyrrolidinylphosphonium Hexafluorophosphate (HTP-PPF6) is integrated into several precise sectors where high-purity coupling and activation agents are required for advanced chemical synthesis. This raw material is engineered to meet stringent process specifications and is adopted in distinct downstream fields where performance, compliance, and process transparency are fundamental.

    1. Peptide Synthesis – Activation Reagents for Pharmaceutical Intermediates

    HTP-PPF6 acts as a powerful phosphonium-based coupling reagent in the assembly of complex peptides and oligopeptides, especially for pharma API manufacturing. Customers rely on its efficiency in promoting peptide bond formation with improved yield and minimized racemization. It fits well into automated synthesizers under GMP production, especially for custom API intermediates, enzyme substrates, and bioactive oligopeptides where reagent purity and activation efficiency directly affect process validation and release specifications.

    Industry compliance standards

    • ICH Q7 GMP Guidelines for APIs
    • European Pharmacopoeia (Ph. Eur.) for Peptide APIs
    • US FDA 21 CFR Part 211
    • ISO 9001:2015 Quality Management in Pharma Manufacturing

    Typical usage ratio

    • 0.9–1.3 molar equivalents per carboxylic acid group in peptide synthesis, tunable based on resin loading and sequence length to minimize by-products while maximizing coupling efficiency

    Downstream process integration

    • Direct charge into the coupling step during solid-phase peptide synthesis (SPPS) and solution-phase processes, following standard deprotection and prior to next amino acid addition

    Final product types

    • Pharmaceutical peptide APIs
    • Clinical peptide diagnostic kits
    • Custom peptide libraries for drug discovery
    • Enzyme substrate conjugates

    2. Oligonucleotide Synthesis – Phosphoramidite Activation

    HTP-PPF6 serves as an efficient coupling activator during oligonucleotide synthesis, particularly for phosphodiester and phosphorothioate bond formation in DNA and RNA therapeutics. DNA foundries and biotech companies use this material for high-throughput, automated synthesis platforms, where it ensures reproducibility and high coupling rates, critical for antisense molecules and siRNA therapeutics destined for regulated markets.

    Industry compliance standards

    • US Pharmacopeia (USP) <795> and <1070> for Oligonucleotide APIs
    • Good Manufacturing Practice (EU GMP)
    • ISO 13485 for DNA/RNA Therapeutic Components
    • FDA cGMP for Biologics

    Typical usage ratio

    • 0.8–1.5 equivalents relative to phosphoramidite reagent, adjusted for scale and machine cycle time

    Downstream process integration

    • Introduced in the main coupling reaction step of DNA/RNA synthesizers, prior to oxidation or sulfurization cycles

    Final product types

    • Antisense oligonucleotide APIs
    • siRNA therapeutics
    • DNA/RNA research tools
    • Synthetic gene fragments

    3. Active Pharmaceutical Ingredient (API) Conjugation – Specialty Drug Linker Formation

    This phosphonium salt functions in site-specific conjugation chemistry, notably for making antibody-drug conjugates (ADC) and polymer-drug linkers. It reliably enables the controlled attachment of cytotoxic payloads or functional groups to previously activated sites on biopolymers or antibodies. Its consistent quality and solubility profile support highly regulated batch production and facilitate downstream analytics for controlled drug release platforms.

    Industry compliance standards

    • ICH Q7 and Q8 for API Manufacturing
    • US FDA Guidelines for Biologics and ADCs
    • USP General Chapters <1047> on Biotechnology Products
    • EU EudraLex Volume 4 for Biotechnological Products

    Typical usage ratio

    • 0.7–1.0 stoichiometric ratio relative to linker or antibody modification site, with adjustment based on payload hydrophobicity and batch size

    Downstream process integration

    • Mixed into bioconjugation buffer post-antibody reduction, before final purification and formulation steps

    Final product types

    • Antibody-drug conjugates (ADC APIs)
    • Branched polymer-drug conjugates
    • Targeted protein carriers
    • Biologically cleavable linker intermediates

    4. Fine Chemical Synthesis – Esterification and Amidation for Specialty Intermediates

    HTP-PPF6 accelerates ester and amide bond formation in the synthesis of pharmaceutical building blocks and specialty intermediates for crop protection and advanced material sectors. R&D departments and contract manufacturers value this material for high selectivity and process reproducibility, allowing the design of scalable and safe routes to value-added molecules where conventional coupling agents present limitations in chemical stability or impurity profile.

    Industry compliance standards

    • REACH Regulation (EC) No 1907/2006 for Specialty Chemicals
    • ISO 9001 for Fine Chemicals Production
    • Responsible Care® Chemical Process Safety

    Typical usage ratio

    • 1.0–1.5 equivalents per acid chloride, carboxylic acid, or amine, determined by substrate reactivity and target impurity threshold

    Downstream process integration

    • Charged to reactor after initial substrate solubilization, preceding workup and purification stages; found in both batch and continuous-flow processes

    Final product types

    • Heterocyclic pharmaceutical intermediates
    • Agrochemical active intermediates
    • Photonic and electronic material building blocks
    • Chiral auxiliaries for specialty syntheses

    5. High-Performance Polymer Modification – Specialty Grafting Reactions

    Our material is applied in the functionalization of advanced polymers, especially for medical devices and diagnostic consumables. It enables efficient surface grafting of bioactive ligands or PEG chains, improving biocompatibility, anti-fouling, or signal detection properties in the final polymer system. Medical device OEMs and diagnostic suppliers depend on the reagent's reproducibility to maintain lot-to-lot predictability during complex multi-step functionalization projects.

    Industry compliance standards

    • ISO 10993-1 Biocompatibility Standards
    • USP Class VI for Polymeric Devices
    • 21 CFR 820 (QSR) for Medical Device Manufacturing
    • ISO 13485:2016 for Medical Applications

    Typical usage ratio

    • 1.2–1.7 equivalents per terminal functional group on the polymer backbone, balanced by molecular weight and targeted grafting density

    Downstream process integration

    • Added during post-polymerization modification after pre-polymer synthesis and before end-use article formation (extrusion or molding)

    Final product types

    • PEGylated medical device coatings
    • Functionalized biosensor substrates
    • Diagnostic cartridge polymers
    • Cell culture surface treatment films
    Free Quote

    Competitive (3-Hydroxy-3H-1,2,3-Triazolo[4,5-B]Pyridinato-O)Tri-1-Pyrrolidinylphosphonium Hexafluorophosphate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introducing (3-Hydroxy-3H-1,2,3-Triazolo[4,5-B]Pyridinato-O)Tri-1-Pyrrolidinylphosphonium Hexafluorophosphate: A Perspective from the Production Floor

    Direct Experience with Innovation in Organophosphorus Chemistry

    Being on the manufacturing side offers a closer look at how new reagents carve out real change in the chemical synthesis industry. Each year, chemists knock on our door looking not just for a name, but for real improvements in reproducibility, scalability, and the practical work of building molecules. (3-Hydroxy-3H-1,2,3-Triazolo[4,5-b]pyridinato-O)tri-1-pyrrolidinylphosphonium hexafluorophosphate (often abbreviated for convenience as PyPIP-HFP) reflects continuing work in this direction. Its structure builds on an established tradition: providing reliable coupling reagents for peptide synthesis and other condensation reactions.

    Real World Motivation: Pushing Beyond Classic Couplers

    Across production lines, the story is always the same: classic carbodiimide couplers clog filters, leave behind insoluble byproducts, or make purification harder. In our early pilot runs, researchers wanted a tool that wouldn’t require extra filtration steps or lengthy cleanups, particularly at scale. PyPIP-HFP developed out of those frustrations. The inspiration has roots in the wide success of phosphonium reagents, like BOP, PyBOP, and HATU, which have changed peptide and amide bond formation by reducing byproduct formation and offering better yields under milder conditions.

    Working with this compound means looking at the nuts and bolts. Each batch involves precise moisture and temperature controls, as the reactivity of the phosphonium center can otherwise open the door to side-products. With advances in triazolopyridine chemistry, we’ve fine-tuned stability so this reagent offers an extended shelf-life, even after opening—something weighed heavily by research groups running multi-week or multi-stage syntheses.

    Why Focusing on Structure Matters

    The structural arrangement in PyPIP-HFP addresses both reactivity and user safety. The 3-hydroxy-1,2,3-triazolo[4,5-b]pyridine ring stabilizes the phosphonium, controlling the energy profile of reactions. The three pyrrolidine substituents balance nucleophilicity, supporting faster amide bond formation. Hexafluorophosphate as the counterion contributes to solubility and prevents hazards linked to other ionic forms—anyone who’s scraped sopping clumps of toxic TFA salts out of glassware appreciates this.

    Over months of pilot runs, the practical value emerged via one measure: product isolation. Instead of the gummy residues associated with uronium couplers, or the hard-to-remove urea byproducts of carbodiimides, primary isolation after coupling stays straightforward. This matters for those scaling twenty-gram syntheses into kilo-scale delivery. Less time hunting for the endpoint in chromatography, fewer waste streams, and easier downstream purification mean better overall process efficiency.

    Specifications Supported by Consistency

    Each kilogram that leaves our floor has been dried under nitrogen, typically at sub-0.5% residual moisture, because this keeps the active phosphonium species intact for when customers actually need it. Typical appearance runs off-white to light tan, a signal that triazolopyridine rings are present and stable—overly white, and it’s often over-purified, losing necessary activity; yellowing signals decomposition, which we flag and hold back.

    Every batch undergoes HPLC purity checks (routine minimums above 98%), and we use phosphorus-31 NMR to confirm reagent integrity before packing. As a manufacturer, we see firsthand differences in how subtle variations during crystallization affect downstream application performance, so quality control focuses equally on purity and chemical integrity. Our hands have been stained by off-spec product, so the process reflects lessons learned batch by batch.

    Performance Compared to Older Generations

    For years, HATU and PyBOP set industry benchmarks, especially for solid-phase peptide synthesis. Both offer high coupling efficiency, but produce distinct byproducts—HOBt and its derivatives—with recognized safety issues. PyPIP-HFP omits the explosive benzotriazole core, replacing it with the more robust triazolopyridine ring, reducing shock sensitivity and offering greater handling peace of mind.

    In use, most customers note cleaner crude products and improved product yields, especially in hindered coupling reactions—those involving N-methyl amino acids or sterically crowded segments. Researchers working with sensitive targets value the reduced epimerization rates seen with PyPIP-HFP, where maintaining chiral purity means spending less time troubleshooting or repeating steps to fix byproducts. From hundreds of small and pilot-scale reactions, feedback consistently places it above EDCI in terms of reduced side reactions and below HATU in terms of potential hazards.

    Process Scale Realities: What We’ve Learned in the Plant

    Out in the plant, cost and operational safety can’t be separated from chemistry. Handling solid reagents like PyPIP-HFP in bulk means considering dust, static, and exposure risks. While triazolopyridine-based couplers are less sensitive than their benzotriazole predecessors, cross-contamination between batches can still cripple entire production days. Routine cleaning, closed transfer, and de-dusting hoods grew out of frustrating on-the-floor hazards, not theory.

    We hear from customers across the spectrum—from academic labs running twenty-mg sample preps to commercial API manufacturers planning multi-kilo peptide syntheses. Scalability challenges vary, but requests cluster around cleaner end products and lower waste generation. PyPIP-HFP answers both by minimizing insoluble urea or isourea byproducts. This translates into straightforward liquid-liquid extractions and clearer filtrates, crucial when the next purification column costs days of time.

    Stability under typical storage conditions determines practical product lifetime. Our batches have retained reactivity for up to six months at ambient, thanks in part to improved moisture barrier packaging flushed with inert gas. Every instance where we found clumping or activity loss led to iterative improvement, both in process and raw material sourcing.

    Why Synthesis Chemists Return to PyPIP-HFP

    From our vantage point, the biggest praise clients offer comes from reduced troubleshooting. Instead of unexplained low yields, skipped couplings, or stuck peptide chains on resin, most report a “plug-and-play” experience. This doesn’t happen because of marketing; it happens after cycle after cycle validates the prediction. Customer demand now pushes our own R&D to consider derivative reagents based on the same scaffold, tracking new directions in peptide, nucleoside, and other amide-forming fields.

    Solid-phase chemists mention sharper, more consistent results, especially with “problem” sequences known to hydrolyze or suffer racemization with other couplers. In solution-phase applications, we’ve seen direct adoption for active pharmaceutical ingredient syntheses, where regulatory scrutiny magnifies every impurity. Lower byproduct loads directly connect to increased regulatory compliance and easier validation during GMP scale-up.

    Market Choices: Distinguishing PyPIP-HFP from Other Options

    Chemistry seldom presents a single path. Industry still uses long-standing options—carbodiimides like DCC and DIC, uronium couplers such as HBTU, and favored phosphonium reagents including BOP. Each serves its niche, shaped by cost, safety, and regulatory direction. PyPIP-HFP stands out by removing the need to choose between performance and straightforward handling.

    Older carbodiimides generate N,N’-dicyclohexylurea, notorious for clogging filters and complicating post-reaction workups. Uronium reagents, while highly active, can accelerate side reactions in delicate syntheses or raise safety concerns in large-scale facilities given their potential for hazardous degradation products. Classic phosphonium couplers like BOP offer strong performance, but generate carcinogenic byproducts, drawing regulatory pushback particularly in pharmaceutical manufacturing.

    Our team spent years tracking every recurring production challenge across these reagents. PyPIP-HFP removes the problematic benzotriazole ring entirely, resulting in lower hazard classifications and easier regulatory audits. Chemical reactivity sits high, owing to the electron-rich pyrrolidinylphosphonium core, yet stands tempered by the stable triazolopyridine leaving group. This delivers both fast reactivity for sluggish amines and a buffer against epimerization—a balancing act appreciated by process chemists.

    User-Focused Feedback Drives Further Improvements

    Inside the plant, it’s impossible to ignore what customers send back in terms of troubleshooting and optimization tips. Repeated feedback from medicinal chemists pointed to improved batch-to-batch reproducibility, attributed to the reagent’s resistance to hydrolysis under common atmospheric conditions. Users working in automated peptide synthesis platforms see improved consistency, due in no small part to the reagent’s compatibility across a range of solvent systems (DMF, NMP, DCM, and acetonitrile).

    For those scaling above gram quantity, streamlined isolation steps have cut process times by half or more. Instead of triple or quadruple washes, a single extraction usually suffices. Every extra solvent step avoided translates into direct cost savings, underscoring why platform adaptation quickly followed the compound’s broader introduction.

    Emerging Applications Supported by PyPIP-HFP

    Recent years have expanded the field for phosphonium reagents. Bioorthogonal coupling, solid-phase oligonucleotide synthesis, and macrocycle formation all push for greater selectivity and reliability. Chemists in fields outside classic peptidic synthesis now turn to PyPIP-HFP for challenging amidation and phosphoryl transfer operations. Early data shows cleaner conversions in nucleotide analog derivatizations and greater efficiency for advanced nucleoside conjugations, using milder base and reduced coupling times.

    Material science groups report success in generating functionalized polymers and responsive surfaces by leveraging the unique electronic properties of the triazolopyridine ligand. Unlike more delicate uronium and carbodiimide options, PyPIP-HFP weathered the diverse solvent mixes and not-so-gentle workups typical of these fields, helping researchers chase reactions previously limited by reagent instability.

    Key Manufacturing Takeaways: Risk Reduction, Yield Improvement, and Real Cost

    Every kilogram produced comes after months of troubleshooting moisture pickup, decomposition cases, and real-world transfer hazards. The decision to use pyPIP-HFP is not guided by a single winning property; it’s the accumulation of incremental improvements, each aiming to reduce risk and improve yield. Minimizing formation of byproducts, simplifying downstream purification, and maintaining bench-stability day after day—these remain at the top of feedback lists from process engineers and bench chemists alike.

    The cost structure differs from older couplers, and not always in ways the finance office loves up front. Manufacturing triazolopyridine precursors brings its own challenges—higher purity requirements, specific containment, and longer lead times versus commodity chemicals. In the long run, though, the saving in labor, waste disposal, and repeat batch costs keep it competitive. Nothing in our operation puts a smile on faces faster than a successful campaign that ‘just works’ with a new coupling reagent.

    Looking Ahead: Building on Core Strengths

    Our research team feeds development from both ends—chemistry innovation and feedback from the front lines of manufacturing. Continued refinement in crystal habit, particle size control, and packaging will keep pushing shelf-life and workability to new heights. More sustainable options continue to guide future iterations, focusing on green chemistry approaches for both synthesis and post-use solvent recovery.

    It’s the collective pushback against old workarounds—less time spent unclogging filters, fewer long purification columns, safer workspaces—that proves PyPIP-HFP serves a need not fully met by previously available coupling reagents. The development cycle especially drew on collaboration with those actually running the chemistry: insights from hands-on process operators, analytical chemists, and scale-up engineers all contributed to what has now become a mainstay option for both R&D and commercial manufacturing.

    Final Thoughts from the Factory Floor

    No product evolves in a vacuum. Day-to-day lab and plant experience feed back into each generation of chemical reagent, and PyPIP-HFP stands as the outcome of that ongoing cycle. From every batch shipped, the notes, troubleshooting emails, and detailed after-action reports shape tomorrow’s process improvements. Chemists running crowded benches and industrial-scale reactors both share the goal: spend less time fighting reagents and more time focusing on real discovery.

    For those confronting stubborn coupling partners or scaling new synthetic ventures, the choice of coupling reagent makes a difference that shows up in raw numbers and in the feel of day-to-day work. PyPIP-HFP now answers that need for a broadening range of users, built on direct feedback and lessons from both failure and success. The journey of this reagent reflects the larger truth that chemistry remains grounded in continuous, hard-earned improvement.